Tugal, Baby Boy .
HRN: 22-65-77 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2023
AMPICILLIN 250MG (VIAL)
04/24/2023
04/30/2023
IVT
250mg
Q12
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes